Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer

Parijatham S Thomas1,2, Anisha B Patel3, J Jack Lee4

  • 1Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Abstract